Chronic rhinosinusitis with nasal polyps
Not recruitingStudy on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma
Study on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma
- Disease:Chronic rhinosinusitis with nasal polyps
- Substances:BenralizumabMometasone Furoate
Poland- Participants:18–64 years · 65+ years
- Substances:Benralizumab
- Sponsor:AstraZeneca AB












